Charles River Laboratories (CRL)

EBITDA Margin

5.51%

TTM · Period ending:

CRL logo

CRL EBITDA Margin

Latest reported5.51%
CRL EBITDA Margin (23.91% → 5.51%)
High-resolution chart · PNG

CRL ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Charles River Laboratories EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
10.2316%
14.3492%
24.9943%
24.8021%
23.1673%
26.2821%
21.4808%
22.3835%
24.6496%
22.4385%
22.4001%
22.0389%
21.9585%
21.634%
22.796%
-18.1005%
21.8869%
-26.4845%
26.1497%
25.8226%
24.488%
26.6385%
27.6467%
26.6832%
25.5269%
27.3761%
26.727%
23.9109%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.